BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: An Y, Yang Q. MiR-21 modulates the polarization of macrophages and increases the effects of M2 macrophages on promoting the chemoresistance of ovarian cancer. Life Sci 2020;242:117162. [PMID: 31837336 DOI: 10.1016/j.lfs.2019.117162] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Chen C, Lin Z, Liu W, Hu Q, Wang J, Zhuang X, Guan S, Wu X, Hu T, Quan S, Jin X, Shen J. Emodin accelerates diabetic wound healing by promoting anti-inflammatory macrophage polarization. European Journal of Pharmacology 2022;936:175329. [DOI: 10.1016/j.ejphar.2022.175329] [Reference Citation Analysis]
2 Sun Z, Wu Y, Gao F, Li H, Wang C, Du L, Dong L, Jiang Y. In situ detection of exosomal RNAs for cancer diagnosis. Acta Biomaterialia 2022. [DOI: 10.1016/j.actbio.2022.10.061] [Reference Citation Analysis]
3 Hashemi M, Mirdamadi MSA, Talebi Y, Khaniabad N, Banaei G, Daneii P, Gholami S, Ghorbani A, Tavakolpournegari A, Farsani ZM, Zarrabi A, Nabavi N, Zandieh MA, Rashidi M, Taheriazam A, Entezari M, Khan H. Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106568] [Reference Citation Analysis]
4 Chen J, Liu D, Yang J, Jin C, Zhao C, Cheng J. Epidermal growth factor activates a hypoxia‐inducible factor 1α–microRNA‐21 axis to inhibit aquaporin 4 in chronic rhinosinusitis. Annals NY Academy of Science 2022. [DOI: 10.1111/nyas.14914] [Reference Citation Analysis]
5 Liu L, Zhuang M, Tu XH, Li CC, Liu HH, Wang J. Bioinformatics analysis of markers based on m6 A related to prognosis combined with immune invasion of renal clear cell carcinoma. Cell Biol Int 2022. [PMID: 36200528 DOI: 10.1002/cbin.11929] [Reference Citation Analysis]
6 Mohd Yasin ZN, Mohd Idrus FN, Hoe CH, Yvonne-tee GB. Macrophage polarization in THP-1 cell line and primary monocytes: A systematic review. Differentiation 2022. [DOI: 10.1016/j.diff.2022.10.001] [Reference Citation Analysis]
7 Li P, Gao C, Chen Z. Effect of Bone Marrow Mesenchymal Stem Cells (BMSCs) with High miR-183-5p Expression on Ovarian Cancer Cells by Regulating Signal Transducer and Activator of Transcription 3 (STAT3). j biomater tissue eng 2022;12:1692-1698. [DOI: 10.1166/jbt.2022.3093] [Reference Citation Analysis]
8 Tang H, Shan J, Liu J, Wang X, Wang F, Han S, Zhao X, Wang J. Molecular subtypes, clinical significance, and tumor immune landscape of angiogenesis-related genes in ovarian cancer. Front Oncol 2022;12:995929. [DOI: 10.3389/fonc.2022.995929] [Reference Citation Analysis]
9 Sajjadi E, Gaudioso G, Terrasi A, Boggio F, Venetis K, Ivanova M, Bertolasi L, Lopez G, Runza L, Premoli A, Lorenzini D, Guerini-rocco E, Ferrero S, Vaira V, Fusco N. Osteoclast-like stromal giant cells in breast cancer likely belong to the spectrum of immunosuppressive tumor-associated macrophages. Front Mol Biosci 2022;9:894247. [DOI: 10.3389/fmolb.2022.894247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Peng C, Li L, Luo G, Tan S, Xia R, Zeng L. Integrated analysis of the M2 macrophage-related signature associated with prognosis in ovarian cancer. Front Oncol 2022;12:986885. [DOI: 10.3389/fonc.2022.986885] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Chen M, Lei N, Tian W, Li Y, Chang L. Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics. Ther Adv Med Oncol 2022;14:17588359221118010. [PMID: 35983027 DOI: 10.1177/17588359221118010] [Reference Citation Analysis]
12 Abdel Rhman M, Pmo O. Potential therapeutic applications of microRNAs in cancer diagnosis and treatment: Sharpening a double-edged sword? Eur J Pharmacol 2022;932:175210. [PMID: 35981607 DOI: 10.1016/j.ejphar.2022.175210] [Reference Citation Analysis]
13 Hao F, Shan C, Zhang Y, Zhang Y, Jia Z. Exosomes Derived from microRNA-21 Overexpressing Neural Progenitor Cells Prevent Hearing Loss from Ischemia-Reperfusion Injury in Mice via Inhibiting the Inflammatory Process in the Cochlea. ACS Chem Neurosci 2022. [PMID: 35939349 DOI: 10.1021/acschemneuro.2c00234] [Reference Citation Analysis]
14 Huang D, Qiu H, Miao L, Guo L, Zhang X, Lin M, Li Z, Li F. Cdc42 promotes thyroid cancer cell proliferation and migration and tumor-associated macrophage polarization through the PTEN/AKT pathway. J Biochem Mol Toxicol 2022;:e23115. [PMID: 35822655 DOI: 10.1002/jbt.23115] [Reference Citation Analysis]
15 Li L, Chen D, Luo X, Wang Z, Yu H, Gao W, Zhong W. Identification of CD8+ T Cell Related Biomarkers in Ovarian Cancer. Front Genet 2022;13:860161. [PMID: 35711935 DOI: 10.3389/fgene.2022.860161] [Reference Citation Analysis]
16 Stieg DC, Wang Y, Liu LZ, Jiang BH. ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance. Int J Mol Sci 2022;23:6702. [PMID: 35743145 DOI: 10.3390/ijms23126702] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Xu WX, Wang DD, Zhao ZQ, Zhang HD, Yang SJ, Zhang Q, Li L, Zhang J. Exosomal microRNAs shuttling between tumor cells and macrophages: cellular interactions and novel therapeutic strategies. Cancer Cell Int 2022;22:190. [PMID: 35578228 DOI: 10.1186/s12935-022-02594-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 Li M, Jiang H, Chen S, Ma Y. GATA binding protein 1 recruits histone deacetylase 2 to the promoter region of nuclear receptor binding protein 2 to affect the tumor microenvironment and malignancy of thyroid carcinoma. Bioengineered 2022;13:11320-41. [PMID: 35491849 DOI: 10.1080/21655979.2022.2068921] [Reference Citation Analysis]
19 Zhu S, Sun J, Liu X, Shao H, Feng C, Wang Z, Zheng X, Wei S. CTCF-Induced lncRNA C5orf66-AS1 Facilitates the Progression of Triple-Negative Breast Cancer via Sponging miR-149-5p to Up-Regulate CTCF and CTNNB1 to Activate Wnt/β-Catenin Pathway. Mol Cell Biol. [DOI: 10.1128/mcb.00188-21] [Reference Citation Analysis]
20 Kim EH, Lee J, Kwak G, Jang H, Kim H, Cho H, Jang Y, Choi J, Chi S, Kim K, Kwon IC, Yang Y, Kim SH. PDL1-binding peptide/anti-miRNA21 conjugate as a therapeutic modality for PD-L1high tumors and TAMs. Journal of Controlled Release 2022. [DOI: 10.1016/j.jconrel.2022.02.031] [Reference Citation Analysis]
21 Yang J, Zhang Q, Zhao P, Qiao T, Cao Z, Gao F, Liu M, Wu S. DNA methyltransferase 3 beta regulates promoter methylation of microRNA-149 to augment esophageal squamous cell carcinoma development through the ring finger protein 2/Wnt/β-catenin axis. Bioengineered 2022;13:4010-27. [PMID: 35129056 DOI: 10.1080/21655979.2022.2031411] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Liu P, Chen R, Zhang X, Fu R, Tao L, Jia W. Combined PD-1/PD-L1 and tumor-infiltrating immune cells redefined a unique molecular subtype of high-grade serous ovarian carcinoma. BMC Genomics 2022;23. [DOI: 10.1186/s12864-021-08265-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Tse J, Pierce T, Carli ALE, Alorro MG, Thiem S, Marcusson EG, Ernst M, Buchert M. Onco-miR-21 Promotes Stat3-Dependent Gastric Cancer Progression. Cancers (Basel) 2022;14:264. [PMID: 35053428 DOI: 10.3390/cancers14020264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Liu M, Zhang H, Li Y, Wang S. Noncoding RNAs Interplay in Ovarian Cancer Therapy and Drug Resistance. Cancer Biother Radiopharm 2022. [PMID: 35133881 DOI: 10.1089/cbr.2021.0339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Dai T, Liang J, Liu W, Zou Y, Niu F, Li M, Zhang H, Li C, Fan M, Cui G. The miRNA mir-582-3p suppresses ovarian cancer progression by targeting AKT/MTOR signaling via lncRNA TUG1. Bioengineered 2021;12:10771-81. [PMID: 34793263 DOI: 10.1080/21655979.2021.2003662] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
26 Li W, Xin X, Li X, Geng J, Sun Y. Exosomes secreted by M2 macrophages promote cancer stemness of hepatocellular carcinoma via the miR-27a-3p/TXNIP pathways. Int Immunopharmacol 2021;101:107585. [PMID: 34601333 DOI: 10.1016/j.intimp.2021.107585] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
27 Guo E, Mao X, Wang X, Guo L, An C, Zhang C, Song K, Wang G, Duan C, Zhang X, Yang X, Yuan Z, Sun J, Li X, Yang W, Meng H, Miao S. Alternatively spliced ANLN isoforms synergistically contribute to the progression of head and neck squamous cell carcinoma. Cell Death Dis 2021;12:764. [PMID: 34344861 DOI: 10.1038/s41419-021-04063-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
28 Varikuti S, Verma C, Holcomb E, Jha BK, Viana A, Maryala R, Lamenza F, McElwain BK, Doni NY, Papenfuss T, Oghumu S, Gannavaram S, Nakhasi HL, Satoskar AR. MicroRNA-21 Deficiency Promotes the Early Th1 Immune Response and Resistance toward Visceral Leishmaniasis. J Immunol 2021;207:1322-32. [PMID: 34341171 DOI: 10.4049/jimmunol.2001099] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
29 Luo X, Xu J, Yu J, Yi P. Shaping Immune Responses in the Tumor Microenvironment of Ovarian Cancer. Front Immunol 2021;12:692360. [PMID: 34248988 DOI: 10.3389/fimmu.2021.692360] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
30 Xiong J, He X, Xu Y, Zhang W, Fu F. MiR-200b is upregulated in plasma-derived exosomes and functions as an oncogene by promoting macrophage M2 polarization in ovarian cancer. J Ovarian Res 2021;14:74. [PMID: 34078414 DOI: 10.1186/s13048-021-00826-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
31 Kwiatkowska I, Hermanowicz JM, Przybyszewska-Podstawka A, Pawlak D. Not Only Immune Escape-The Confusing Role of the TRP Metabolic Pathway in Carcinogenesis. Cancers (Basel) 2021;13:2667. [PMID: 34071442 DOI: 10.3390/cancers13112667] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Li JX, Li Y, Xia T, Rong FY. miR-21 Exerts Anti-proliferative and Pro-apoptotic Effects in LPS-induced WI-38 Cells via Directly Targeting TIMP3. Cell Biochem Biophys 2021. [PMID: 33942238 DOI: 10.1007/s12013-021-00987-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
33 Mondal P, Kaur B, Natesh J, Meeran SM. The emerging role of miRNA in the perturbation of tumor immune microenvironment in chemoresistance: Therapeutic implications. Semin Cell Dev Biol 2021:S1084-9521(21)00074-4. [PMID: 33865701 DOI: 10.1016/j.semcdb.2021.04.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
34 Liu J, Tan Z, He J, Jin T, Han Y, Hu L, Song J, Huang S. Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value. Biosci Rep 2020;40:BSR20201431. [PMID: 33043974 DOI: 10.1042/BSR20201431] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
35 Chen YC, Lai YS, Hsuuw YD, Chang KT. Withholding of M-CSF Supplement Reprograms Macrophages to M2-Like via Endogenous CSF-1 Activation. Int J Mol Sci 2021;22:3532. [PMID: 33805444 DOI: 10.3390/ijms22073532] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
36 Medvedeva GF, Kuzmina DO, Nuzhina J, Shtil AA, Dukhinova MS. How Macrophages Become Transcriptionally Dysregulated: A Hidden Impact of Antitumor Therapy. Int J Mol Sci 2021;22:2662. [PMID: 33800829 DOI: 10.3390/ijms22052662] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Li N, Li B, Zhan X. Comprehensive Analysis of Tumor Microenvironment Identified Prognostic Immune-Related Gene Signature in Ovarian Cancer. Front Genet 2021;12:616073. [PMID: 33679883 DOI: 10.3389/fgene.2021.616073] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
38 Lei J, Chen P, Zhang F, Zhang N, Zhu J, Wang X, Jiang T. M2 macrophages-derived exosomal microRNA-501-3p promotes the progression of lung cancer via targeting WD repeat domain 82. Cancer Cell Int 2021;21:91. [PMID: 33546686 DOI: 10.1186/s12935-021-01783-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
39 Taheri M, Shoorei H, Tondro Anamag F, Ghafouri-Fard S, Dinger ME. LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin. Exp Mol Pathol 2021;:104602. [PMID: 33422487 DOI: 10.1016/j.yexmp.2021.104602] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
40 Mirzaei S, Zarrabi A, Asnaf SE, Hashemi F, Zabolian A, Hushmandi K, Raei M, Goharrizi MASB, Makvandi P, Samarghandian S, Najafi M, Ashrafizadeh M, Aref AR, Hamblin MR. The role of microRNA-338-3p in cancer: growth, invasion, chemoresistance, and mediators. Life Sci 2021;268:119005. [PMID: 33421526 DOI: 10.1016/j.lfs.2020.119005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 33.0] [Reference Citation Analysis]
41 Yuan L, An Q, Liu T, Song J. Classification and clinical value of three immune subtypes of ovarian cancer based on transcriptome data. All Life 2021;14:963-75. [DOI: 10.1080/26895293.2021.1987339] [Reference Citation Analysis]
42 Ryu KJ, Lee JY, Choi ME, Yoon SE, Cho J, Ko YH, Shim JH, Kim WS, Park C, Kim SJ. Serum-Derived Exosomal MicroRNA Profiles Can Predict Poor Survival Outcomes in Patients with Extranodal Natural Killer/T-Cell Lymphoma. Cancers (Basel) 2020;12:E3548. [PMID: 33261029 DOI: 10.3390/cancers12123548] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
43 Liu Y, Wang R. Immunotherapy Targeting Tumor-Associated Macrophages. Front Med (Lausanne) 2020;7:583708. [PMID: 33251232 DOI: 10.3389/fmed.2020.583708] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]